Merus Labs International Inc (USA) news

   Watch this stock
Showing stories 1 - 10 of about 88   

Articles published

MSLI 2.33 -0.17 (-6.80%)
price chart
Merus Labs International Inc looks ready for more deals
But when it comes to specialty pharmaceutical company Merus Labs International Inc., it's hard not to expect more M&A.
Merus Labs International Price Target Raised to C$3.50 at Canaccord Genuity ...  Dakota Financial News
Merus Labs International Inc. Completes $20 Million Bought Deal Financing
Merus Labs International Inc. ("Merus" or the "Company") (TSX:MSL)(NASDAQ:MSLI) is pleased to announce today the closing of its previously announced bought deal financing with a syndicate of investment dealers (the "Underwriters") co-led by Cormark ...
Related articles »  
Merus Labs International Inc. Announces Completion of $7 Million Financing ...
14, 2014) - Merus Labs International Inc. ("Merus" or the "Company") (TSX:MSL)(NASDAQ:MSLI) is pleased to announce that, further to its news release dated July 4, 2014, the Company has today completed the financing acquisition transaction with Dacha ...
Related articles »  
Mid-Day Changers: WPCS International Incorporated (WPCS), Merus Labs ...
WPCS International Incorporated (WPCS) of the Technology sector has changed by 4.37% and at noon is trading with a volume of 4,822 shares with a volatility this week of 8.64%.
Merus Labs International Inc adds to its unusual path with its largest equity ...
The creative history of Merus Labs International Inc. continued Monday when the now Toronto-based company announced a $60 million bought deal: the sale of 19.672 million shares at $3.05 a share.
Merus Labs International Inc. Announces Aggregate $21 Million Financing ...
TORONTO, ONTARIO--(Marketwired - June 10, 2014) - Merus Labs International Inc. ("Merus" or the "Company") (TSX:MSL)(NASDAQ:MSLI) is pleased to announce today that the Company has entered into a private placement subscription agreement to ...
Related articles »  
Merus Labs International: A Pharma Stock With Growth Potential
It's Merus Labs International Inc. (TSX: MSL) (MSLI), a specialty pharmaceutical company focused on acquiring established products.
Update on Merus Labs International, Athabasca Minerals Inc, Enghouse ...
Contributing editor Ryan Irvine joins us this week with a detailed review of some of his previous recommendations. Ryan is the CEO of KeyStone Financial and one of the country's top experts in small cap stocks.
Merus Labs International Given New C$4.00 Price Target at Canaccord Genuity ...
Merus Labs International Inc logo Merus Labs International (TSE:MSL) had its price target increased by Canaccord Genuity from C$3.50 to C$4.00 in a research report sent to investors on Monday morning.
Versatile News at Street: Merus Labs International Inc. (NASDAQ:MSLI ...  eMarketsDaily
Merus Labs International Given "Buy" Rating at LB Securities (MSLI)  Mideast Time
Merus Labs International Inc. Announces Acquisition of Sintrom(R)
8, 2014) - Merus Labs International Inc. ("Merus" or the "Company") (TSX:MSL)(NASDAQ:MSLI) is pleased to announce that one of its wholly owned subsidiaries has acquired from Novartis AG ("Novartis"), in certain European countries, the rights to ...
Merus Labs International (T.MSL) subsidiary buys rights to anticoagulant ...  Stockhouse
Related articles »